Artrya LimitedASX: AYA

AGM Chairmans Address and CEO Presentation

· Issued by Artrya Limited via ASX

Filed with ASX · · 25 pages · English

Summary by 6ix AI

Artrya Limited has released the Chair and CEO's address and presentation for its Annual General Meeting, detailing the company's progress and future plans in the medical technology sector focused on coronary artery disease management. The Chair highlighted significant commercial traction, including multi-year contracts with five U.S. health systems and the integration of their Salix® platform to enhance patient care. The CEO's presentation emphasized the growing market opportunity and the company's strategic priorities for the upcoming year, including expanding customer bases and increasing scan volumes.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Coronary Artery Disease. We see you. 2026 Chair and CEO Annual General Meeting Address and Presentation PERTH, Australia, 13 November 2026: Artrya Limited (ASX: AYA) (Artrya or the Company), a medical technology ® company commercialising its Salix AI-powered cloud platform, for the real time,...

Artrya Limited on 6ix

In the deck

Story so far

Earlier from Artrya

Later from Artrya

All Artrya news releases